Eva Versteijne

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Eva Versteijne, Mustafa Suker, Karin Groothuis et al. · Journal of Clinical Oncology · 2020 · 1K citations · Full text

Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.

Geertjan van Tienhoven, Eva Versteijne, Mustafa Suker et al. · Journal of Clinical Oncology · 2018 · 159 citations

Surgical Oncology, Gastroenterology, Adjuvant Chemotherapy +17

Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern

Eva Versteijne, Hanneke W.M. van Laarhoven, Jeanin E. van Hooft et al. · Diseases of the Esophagus · 2014 · 94 citations · Full text

Adaptive Radiotherapy, Esophagus, Definitive Chemoradiation +13

Same-day adaptive palliative radiotherapy without prior CT simulation: Early outcomes in the FAST-METS study

Koen J. Nelissen, Eva Versteijne, Suresh Senan et al. · Radiotherapy and Oncology · 2023 · 72 citations · Full text

Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial)

Jelle C. van Dongen, Mustafa Suker, Eva Versteijne et al. · Annals of Surgery · 2020 · 51 citations · Full text